{"id":43924,"date":"2022-05-16T11:02:10","date_gmt":"2022-05-16T09:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/"},"modified":"2022-05-16T11:02:10","modified_gmt":"2022-05-16T09:02:10","slug":"itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/","title":{"rendered":"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022"},"content":{"rendered":"
\n

GARCHING, Germany & MUNICH–(BUSINESS WIRE)–ITM Isotope Technologies Munich SE<\/a> (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a scientific symposium on precision oncology titled \u201cTargeted Radionuclide Therapy \u2013 present and future prospects\u201d<\/b> held as an ancillary event in parallel to the 2022 ASCO\u00ae<\/sup> Annual Meeting. The symposium will feature key opinion leaders in the field and will be held in a hybrid format on June 03, 2022 from 11:00 am \u2013 12:30 pm CST in the Hyatt Regency McCormick Place, in Chicago, USA and online<\/b>.\n<\/p>\n

<\/a><\/p>\n

\nTargeted Radionuclide Therapy is an approach to treating a variety of cancer types. As new areas of interest and advancing approaches to implementing this uniquely selective therapeutic modality continue to be highlighted, the session will offer an overview of the key topics. The panel will focus on the clinical application of Targeted Radionuclide Therapy in the treatment of neuroendocrine tumors, prostate cancer and potential future prospects. They will also spotlight the benefits and risks of this therapeutic approach, address any challenges that may be encountered, and provide valuable insights to their patient management experiences. Participants will be able to interact with the speakers in a Q&A session at the end of the event.\n<\/p>\n

\nScientific Program and Speakers:<\/span><\/b>\n<\/p>\n

\nWelcome and Introduction
\n
<\/b>Pamela Kunz, MD
\n
Smilow Cancer Hospital and Yale Cancer Center\n<\/p>\n

\nClinical Application of Targeted Radionuclide Therapy in Neuroendocrine Tumors
\n
<\/b>Pamela Kunz, MD (20min)
\n
Smilow Cancer Hospital and Yale Cancer Center, New Haven\n<\/p>\n

\nClinical Application of Targeted Radionuclide Therapy in Prostate Cancer
\n
<\/b>Michael Morris, MD (20 min)
\n
Memorial Sloan Kettering Cancer Center, New York\n<\/p>\n

\nPersonalizing the Targeted Radionuclide Therapy, Advancements and Challenges
\n
<\/strong>Thomas Hope, MD (20min)
\n
University of California, San Francisco\n<\/p>\n

\nThe Future of Targeted Radionuclide Therapy
\n
<\/b>Wolfgang Weber, MD, PhD (20min)
\n
Klinikum rechts der Isar (the University Hospital of the Technical University of Munich)\n<\/p>\n

\nDiscussion & Closing Remarks
\n
<\/b>Pamela Kunz, MD\n<\/p>\n

\nFor the full scientific program and registration form please click here:
\n
<\/b>https:\/\/cvent.me\/o2waV8<\/a>\n<\/p>\n

\nThe symposium will be recorded, and available on demand for 6 months after the event.\n<\/p>\n

\nThe event is not sponsored, endorsed, or accredited by ASCO\u00ae<\/sup>, CancerLinQ\u00ae<\/sup>, or Conquer Cancer\u00ae<\/sup> the ASCO Foundation.\n<\/p>\n

\nAbout Targeted Radionuclide Therapy<\/b>\n<\/p>\n

\nTargeted Radionuclide Therapy is an emerging class of cancer therapeutics, which seeks to deliver radiation directly to the tumor while minimizing radiation exposure to normal tissue. Targeted radiopharmaceuticals are created by linking a therapeutic radioisotope to a targeting molecule (e.g., peptide, antibody, small molecule) that can precisely recognize tumor cells and bind to tumor-specific characteristics, like receptors on the tumor cell surface. As a result, the radioisotope accumulates at the tumor site and decays, releasing a small amount of ionizing radiation, thereby destroying tumor tissue. The highly precise localization enables targeted treatment with minimal impact to healthy surrounding tissue.\n<\/p>\n

\nITM Isotope Technologies Munich SE<\/b>\n<\/p>\n

\nITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including two phase III studies, combining the company\u2019s high-quality radioisotopes with a range of targeting molecules. By leveraging our nearly two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life. Further information at: www.itm-radiopharma.com<\/a>\n<\/p>\n\n\n\n\n\n
\n

\nAbout ITM Isotope Technologies Munich SE<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nExecutive Board: Steffen Schuster (CEO), Dr. Klaus Maleck (CFO) – Supervisory Board: Udo J Vetter (Chairman) – Registered Office: Garching\/Munich\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDistrict Court of Munich – Commercial Register 269592 – Phone: +49 (0)89 329 8986 6000 – Fax: +49 (0)89 329 8986 6061 – Email: info@itm-radiopharma.com<\/a>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTax Number: 143\/100\/82466 – VAT Number: DE813228901 – Deutsche Bank Freiburg – IBAN: DE52680700300022816300 – BIC: DEUTDE6F\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n\u00a0\n<\/p>\n

Contacts<\/b> <\/p>\n

\nITM Contact<\/b>
Corporate Communications<\/b>
Julia Hofmann \/ Susanne Karlsson
\n
Phone: +49 89 329 8986 1502
\n
Email: communications@itm-radiopharma.com<\/a><\/p>\n

Investor Relations<\/b>
Ben Orzelek
\n
Phone: +49 89 329 8986 1009
\n
Email: Ben.Orzelek@itm-radiopharma.com<\/a><\/p>\n

ITM Media Requests
\n
Trophic Communications
\n
<\/b>Stephanie May or Valeria Fisher
\n
Phone: +49 171 185 56 82
\n
Email: itm@trophic.eu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

GARCHING, Germany & MUNICH–(BUSINESS WIRE)–ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a scientific symposium on precision oncology titled \u201cTargeted Radionuclide Therapy \u2013 present and future prospects\u201d held as an ancillary event in parallel to the 2022 ASCO\u00ae Annual Meeting. The symposium will feature key opinion … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-43924","6":"format-standard","7":"category-industry"},"yoast_head":"\nITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"GARCHING, Germany & MUNICH–(BUSINESS WIRE)–ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a scientific symposium on precision oncology titled \u201cTargeted Radionuclide Therapy \u2013 present and future prospects\u201d held as an ancillary event in parallel to the 2022 ASCO\u00ae Annual Meeting. The symposium will feature key opinion ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-16T09:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220516005455\/en\/1236282\/21\/ITM_Logo_with_Claim.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022\",\"datePublished\":\"2022-05-16T09:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/\"},\"wordCount\":698,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220516005455\\\/en\\\/1236282\\\/21\\\/ITM_Logo_with_Claim.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/\",\"name\":\"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220516005455\\\/en\\\/1236282\\\/21\\\/ITM_Logo_with_Claim.jpg\",\"datePublished\":\"2022-05-16T09:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220516005455\\\/en\\\/1236282\\\/21\\\/ITM_Logo_with_Claim.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220516005455\\\/en\\\/1236282\\\/21\\\/ITM_Logo_with_Claim.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/","og_locale":"en_US","og_type":"article","og_title":"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022 - Pharma Trend","og_description":"GARCHING, Germany & MUNICH–(BUSINESS WIRE)–ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a scientific symposium on precision oncology titled \u201cTargeted Radionuclide Therapy \u2013 present and future prospects\u201d held as an ancillary event in parallel to the 2022 ASCO\u00ae Annual Meeting. The symposium will feature key opinion ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-16T09:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220516005455\/en\/1236282\/21\/ITM_Logo_with_Claim.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022","datePublished":"2022-05-16T09:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/"},"wordCount":698,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220516005455\/en\/1236282\/21\/ITM_Logo_with_Claim.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/","url":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/","name":"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220516005455\/en\/1236282\/21\/ITM_Logo_with_Claim.jpg","datePublished":"2022-05-16T09:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220516005455\/en\/1236282\/21\/ITM_Logo_with_Claim.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220516005455\/en\/1236282\/21\/ITM_Logo_with_Claim.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/itm-to-host-scientific-precision-oncology-symposium-in-parallel-to-the-asco-annual-meeting-on-friday-june-03-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ITM to Host Scientific Precision Oncology Symposium in Parallel to the ASCO Annual Meeting on Friday, June 03, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=43924"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43924\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=43924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=43924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=43924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}